Daily Stock Analysis, AKER, Akers Biosciences Inc, priceseries

Akers Biosciences Inc. Daily Stock Analysis
Stock Information
Open
7.67
Close
7.48
High
8.35
Low
6.69
Previous Close
7.64
Daily Price Gain
-0.16
YTD High
10.48
YTD High Date
Feb 16, 2021
YTD Low
3.30
YTD Low Date
May 17, 2021
YTD Price Change
3.28
YTD Gain
78.10%
52 Week High
10.48
52 Week High Date
Feb 16, 2021
52 Week Low
3.30
52 Week Low Date
May 17, 2021
52 Week Price Change
3.38
52 Week Gain
82.44%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 22. 2017
480.00
Apr 3. 2017
615.02
8 Trading Days
28.13%
Link
LONG
Jan 11. 2018
69.12
Feb 13. 2018
149.89
22 Trading Days
116.86%
Link
LONG
Feb 16. 2018
153.60
Mar 7. 2018
251.40
12 Trading Days
63.67%
Link
LONG
Mar 15. 2018
261.12
Mar 28. 2018
296.19
9 Trading Days
13.43%
Link
LONG
Sep 25. 2018
101.38
Oct 8. 2018
125.04
9 Trading Days
23.34%
Link
LONG
Dec 27. 2018
47.90
Jan 22. 2019
64.25
16 Trading Days
34.12%
Link
LONG
Aug 9. 2019
20.64
Aug 15. 2019
22.08
4 Trading Days
6.98%
Link
LONG
Apr 6. 2020
9.38
Apr 9. 2020
10.01
3 Trading Days
6.72%
Link
LONG
Jul 16. 2020
8.58
Jul 27. 2020
9.26
7 Trading Days
7.95%
Link
LONG
Jul 30. 2020
10.98
Jul 31. 2020
11.74
1 Trading Days
6.92%
Link
LONG
Jan 4. 2021
4.20
Jan 28. 2021
5.29
17 Trading Days
25.91%
Link
LONG
Feb 4. 2021
5.78
Feb 19. 2021
7.10
10 Trading Days
22.90%
Link
LONG
Jun 11. 2021
4.58
Jul 7. 2021
5.88
17 Trading Days
28.46%
Link
LONG
Aug 20. 2021
5.38
Sep 14. 2021
6.84
16 Trading Days
27.17%
Link
Company Information
Stock Symbol
AKER
Exchange
NasdaqCM
Company URL
http://www.akersbio.com
Company Phone
856-848-8698
CEO
John J. Gormally
Headquarters
New Jersey
Business Address
201 GROVE RD, THOROFARE, NJ 08086
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Instruments & Supplies
CIK
0001321834
About

Akers Biosciences, Inc. is the developer of health information technologies. It engages in the developing, manufacturing, and supplying screening and testing products to deliver healthcare information to consumers and healthcare providers. Its products include clinical diagnostics, safety diagnostics, wellness products, and tests in development. The company was founded by Raymond Francis Akers, Jr. and Raymond F. Akers, Sr. on March 8, 1989 and is headquartered in West Deptford, NJ.

Description

Akers Biosciences, Inc., together with its subsidiaries, focuses on the development and sale of disposable diagnostic testing devices to facilitate time sensitive therapeutic decisions in the United States and internationally. The company offers BreathScan/CHUBE, a disposable breath alcohol detector; BreathScan PRO, a quantitative breath alcohol detection system; METRON, a disposable breath ketone device to monitor weight loss; VIVO for the measurement of biological markers for oxidative stress that relates to cellular damage non-invasively; PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid assay for detecting heparin-induced thrombocytopenia antibodies; seraSTAT, a device to separate rapid blood cells; and Tri-Cholesterol Check' to estimate high density lipoprotein cholesterol and low density lipo protein levels. It is also involved in the development of Breath Ketone Check', a disposable breath ketone device for diabetic monitoring, and management of senile dementia and alzheimers disease patients; Breath PulmoHealth Check', a suite of breath tests for biomarkers indicating asthma, chronic obstructive pulmonary disease, and lung cancer; and PIFA PLUSS that provides rapid tests for various infectious diseases. The company was founded in 1989 and is headquartered in Thorofare, New Jersey.